Company News in the Life Science Industry

»

Reset 

European Hematology Association: Global Trial of the Efficacy and Safety of CTL019 in Adult Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma: An Interim Analysis of the JULIET Study

MADRID, June 24, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 24 Jun 2017
Related companies:  Shanghai Institute of Hematology | Blood Disease Hospital of Tianjin Institute of Hematology

European Hematology Association: Multicenter Open-label Phase 2 Study of ibrutinib in Chronic Graft Versus Host Disease (cGVHD) After Failure of Corticosteroids

MADRID, June 24, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 24 Jun 2017
Related companies:  Shanghai Institute of Hematology | Blood Disease Hospital of Tianjin Institute of Hematology

HARMONY: European Network of Excellence in Hematology and Big Data to Present New Bench-To-Bedside Projects During the 22nd Annual Congress of the European Hematology Association

MADRID, June 24, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 24 Jun 2017
Related companies:  Shanghai Institute of Hematology | Blood Disease Hospital of Tianjin Institute of Hematology

European Hematology Association: Bleeding or Clotting in Elderly Patients with Cancer-Associated Venous Thromboembolism: Which is Worse?

MADRID, June 24, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 24 Jun 2017
Related companies:  Shanghai Institute of Hematology | Blood Disease Hospital of Tianjin Institute of Hematology

European Hematology Association: Clinical and Biologic Covariates of Outcomes in ZUMA-1: A Pivotal Trial of Axicabtagene Ciloleucel (axi-cel; KTE-C19) in Patients with Refractory Aggressive non-Hodgkin Lymphoma (NHL)

MADRID, June 24, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 24 Jun 2017
Related companies:  Shanghai Institute of Hematology | Blood Disease Hospital of Tianjin Institute of Hematology

European Hematology Association: Early Metabolic Response Determination by FDG-PET Allows Substantial Reduction of Chemotherapy and its Toxicity in Patients with Advanced Stage Hodgkin Lymphoma: the GHSG HD18 Study

MADRID, June 24, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 24 Jun 2017
Related companies:  Shanghai Institute of Hematology | Blood Disease Hospital of Tianjin Institute of Hematology

New 10-Minute Saliva and Blood Test to Detect Cancer Early

SINGAPORE, June 23, 2017 /PRNewswire/ -- Researchers at Ram Group's Israeli bio-sensor division have developed a new molecular diagnostics test for early detection of cancers that takes just ten minutes and uses just a couple drops of blood or saliva. The researchers say that the test is extremely... Read more ››

By: PR Newswire Association LLC. - 24 Jun 2017

Sutter Health Physician Organizations Earn Elite Honors

SACRAMENTO, Calif., June 23, 2017 /PRNewswire/ -- Six Sutter Medical Network (SMN) physician organizations that participated in the 2017 Standards of Excellence(TM )(SOE(®)) member survey, including all five medical foundations,... Read more ››

By: PR Newswire Association LLC. - 24 Jun 2017

First of a kind study at UW Medicine finds shells, mortars cause most severe fireworks injuries

SEATTLE, June 23, 2017 /PRNewswire-USNewswire/ -- Certain legal fireworks might be better left on store shelves, a recently published study conducted at UW Medicine's Harborview Medical Center finds.

Read more ››
By: PR Newswire Association LLC. - 24 Jun 2017
Related companies:  UW-Madison Office of Corporate Relations

Paragon 28® launches the PHANTOM(TM) Lapidus Intramedullary Nail System, the first intramedullary nail option to correct hallux valgus at the 1st TMT joint

ENGLEWOOD, Colo., June 23, 2017 /PRNewswire/ -- Today Paragon 28 launches the PHANTOM(TM) Lapidus Intramedullary Nail, the first dedicated intramedullary nail designed specifically for use in correction of arthrodesis of the first TMT joint.

Read more ››
By: PR Newswire Association LLC. - 24 Jun 2017

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Endo International plc - ENDP

NEW YORK, June 23, 2017 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Endo International plc ("Endo" or the "Company") (NASDAQ: ENDP). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com... Read more ››

By: PR Newswire Association LLC. - 24 Jun 2017

Microbiological Testing of Water Market Worth 1.59 Billion USD by 2022

PUNE, India, June 23, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 23 Jun 2017

Oral Care/Oral Hygiene Market Growing at a CAGR of 4.5% During 2017 to 2022 - ReportsnReports.com

PUNE, India, June 23, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 23 Jun 2017

CHILL Registry Launches To Facilitate Collaboration Among Cancer Centers Worldwide

WASHINGTON, June 23, 2017 /PRNewswire/ -- Led by six globally-recognized experts in cancer care, the organization known as CHILL, Cancer-related Hair Loss, International Leadership and Linkage, announced today an initiative to collect and track evidence-based patient information and... Read more ››

By: PR Newswire Association LLC. - 23 Jun 2017

Statement by Chairman and CEO Bernard J. Tyson, Kaiser Permanente, on the Draft Text of the Better Care Reconciliation Act

Read more ››
By: PR Newswire Association LLC. - 23 Jun 2017
Related companies:  Kaiser Permanente | Kaiser Permanente Ventures

Blood Culture Test Market, 2025 - Research and Markets

DUBLIN, June 23, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 23 Jun 2017
Related companies:  Ascendiant Capital Markets LLC

FDA Approves HAEGARDA® (C1 Esterase Inhibitor Subcutaneous [Human]), First and Only Subcutaneous Preventive Treatment for Hereditary Angioedema

Read more ››
By: PR Newswire Association LLC. - 23 Jun 2017
Related companies:  CSL Behring

New Oncology Launch Study Probes the Investment and Staffing Levels Needed to Successfully Launch a Cancer Drug in the United States

CHAPEL HILL, N.C., June 23, 2017 /PRNewswire/ -- New cancer therapies continue to make their way through the development and approval process in the United States as part of the oncology therapeutic area's resurgence.

Read more ››
By: PR Newswire Association LLC. - 23 Jun 2017

American Diabetes Association Urges Senators to Vote Against Proposed Health Care Legislation

Read more ››
By: PR Newswire Association LLC. - 23 Jun 2017
Related companies:  American Diabetes Association

Amgen Receives Positive CHMP Opinion To Expand Use Of Mimpara® (cinacalcet) For The Treatment Of Secondary Hyperparathyroidism In Certain Children With End-Stage Renal Disease On Dialysis

THOUSAND OAKS, Calif., June 23, 2017 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the Marketing Authorization of a pediatric formulation (granules in... Read more ››

By: PR Newswire Association LLC. - 23 Jun 2017
Related companies:  Amgen, Inc.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 40,000 companies